No Data
No Data
CN HEALTH TECH (01069): Li Zhiqiang has been appointed as the CEO of Genmou Biotechnology.
CN HEALTH TECH Group (01069) announced that Li Zhi Liang has been appointed as the company’s wholly-owned subsidiary Genmou (Shenzhen...
CN HEALTH TECH (01069) announced its interim results, with a net income of 4.978 million yuan, a decrease of 97.53% year-on-year.
CN HEALTH TECH (01069) released its interim results for the six months ending December 31, 2024, the group...
CN HEALTH TECH: ANNOUNCEMENT OF INTERIM RESULTSFOR THE SIX MONTHS ENDED 31 DECEMBER 2024
CN HEALTH TECH (01069.HK) intends to hold a Board of Directors meeting on February 28 to approve the interim results.
Gelonghui February 18 - CN HEALTH TECH Group (01069.HK) announced that a Board of Directors meeting will be held on February 28, 2025 (Friday) to consider and approve the group's interim performance announcement for the six months ending December 31, 2024, and to consider the proposal for the payment of an interim dividend (if any).
CN HEALTH TECH: Annual Report 2024
China Health Technology Turns to Profit in FY2024